The FTC expresses “strong concerns” over State regulations offering to provide antitrust immunity to certain healthcare collaborations undertaken with Department of health’s approval and supervision (COPA)

State Regulatory Scheme Offering Antitrust Immunity to Healthcare Collaborations Creates Tension Between Federal and State Antitrust Enforcement* On April 22, 2015, the Federal Trade Commission submitted a public letter to the New York State Department of Health (DOH) expressing “strong concerns” over state regulations offering to provide antitrust immunity to certain healthcare collaborations undertaken with DOH’s approval and supervision. This letter is consistent with the FTC’s continued opposition to grants of immunity from federal antitrust laws based on state action. The letter also presents a meaningful opportunity to re-evaluate the interplay between state and federal antitrust enforcement authority, and the related doctrine of state action immunity, particularly in the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Sheppard Mullin (San Francisco)
  • Sheppard Mullin (Century City)
  • Sheppard Mullin (Century City)

Quotation

Helen Cho Eckert, David R. Garcia, Vinay Bhupathy, The FTC expresses “strong concerns” over State regulations offering to provide antitrust immunity to certain healthcare collaborations undertaken with Department of health’s approval and supervision (COPA), 20 April 2015, e-Competitions April 2015, Art. N° 73540

Visites 106

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues